mRNA Vaccines Clinical Trials Chikungunya Vaccines Viral Vaccines Regulatory Affairs Chikungunya Vaccine Investigational Vaccines Nipah Virus Vaccine Marburg Vaccine Candidates COVID-19 Vaccines Immunotherapy Antiviral Resistance Efficacy Influenza Vaccines HMPV Vaccine H5N1 Vaccines HMPV Vaccine Research H5N1 Vaccine Vaccine Supply Human Health Dengue Vaccine Covid-19 Vaccines Preclinical Research Global Health Initiatives Zika Virus Vaccine Vaccine Regulation Public Health Policy Smallpox Vaccine Vaccine Candidates Malaria Vaccines FDA Regulations Immunization Strategies Nasal Vaccines Immune Response Adjuvants Efficacy Testing High-Cost Vaccines mRNA Technology Oral Cholera Vaccine Public Awareness Clinical Phases Hepatitis B Vaccine Vaccine Legislation Nipah Virus Research Nipah Vaccine Infectious Disease Vaccines Regulatory Bodies Dengue Vaccines CMV Vaccine Efficacy Studies Authorization Human Challenge Trials Jynneos Vaccine Experimental Vaccines
The multilateral grant replaces canceled U.S. support.
